Funding Rounds
Phlox Therapeutics

Phlox Therapeutics Seed Round, November 2024

Phlox Therapeutics

Developer of Ribonucleic acid (RNA)-based gene therapies to treat cardiomyopathies.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $2.00M

Raised Date: 2024-11-14

Investors